Kustatscher, Georg http://orcid.org/0000-0001-8955-0866
Collins, Tom
Gingras, Anne-Claude http://orcid.org/0000-0002-6090-4437
Guo, Tiannan http://orcid.org/0000-0003-3869-7651
Hermjakob, Henning http://orcid.org/0000-0001-8479-0262
Ideker, Trey
Lilley, Kathryn S. http://orcid.org/0000-0003-0594-6543
Lundberg, Emma http://orcid.org/0000-0001-7034-0850
Marcotte, Edward M. http://orcid.org/0000-0001-8808-180X
Ralser, Markus http://orcid.org/0000-0001-9535-7413
Rappsilber, Juri http://orcid.org/0000-0001-5999-1310
Funding for this research was provided by:
Wellcome Trust (203149)
Wellcome Trust (218294)
Article History
First Online: 9 May 2022
Competing interests
: T.G. is a shareholder of Westlake Omics Inc. T.I. is a cofounder of Data4Cure, is on the Scientific Advisory Board and has an equity interest. T.I. is on the Scientific Advisory Board of Ideaya BioSciences and has an equity interest. E.L. is advisor for Pixelgen technologies and Moleculent. E.M.M. is a cofounder, shareholder and scientific board member of Erisyon, Inc. G.K., T.C., A.-C.G., H.H., K.S.L., M.R. and J.R. declare no competing interests.
Free to read: This content has been made available to all.